Detail

Keywords

Colorectal Neoplasms; Liver Neoplasms; Translational Medical Research

Research group(s)

• ARGE Stremitzer (Translational Liver Oncology Research Group)
  Head: Stefan Stremitzer
  Members:
  Stefan Stremitzer

Research interests

Identification of predictive and prognostic biomarkers in patients with primary and secondary malignant liver tumors

Main research focus:

• Colorectal liver metastases
• Hilar cholangiocarcinoma
• Hepatocellular carcinoma

Selected publications

1. Stremitzer, S. et al., 2020. Immune phenotype and histopathological growth pattern in patients with colorectal liver metastases. British Journal of Cancer. Available at: http://dx.doi.org/10.1038/s41416-020-0812-z.
2. Stremitzer, S. et al., 2019. Clinical outcome after resection of early-stage hilar cholangiocarcinoma. European Journal of Surgical Oncology, 45(2), pp.213–217. Available at: http://dx.doi.org/10.1016/j.ejso.2018.09.008.
3. Stift, J. et al., 2018. Microscopic biliary and perineural invasion and clinical outcome after neoadjuvant bevacizumab-based chemotherapy and liver resection in patients with colorectal liver metastases. European Journal of Surgical Oncology, 44(1), pp.139–147. Available at: http://dx.doi.org/10.1016/j.ejso.2017.11.018.
4. Stremitzer, S. et al., 2016. Expression of Genes Involved in Vascular Morphogenesis and Maturation Predicts Efficacy of Bevacizumab-Based Chemotherapy in Patients Undergoing Liver Resection. Molecular Cancer Therapeutics, 15(11), pp.2814–2821. Available at: http://dx.doi.org/10.1158/1535-7163.MCT-16-0275.
5. Stremitzer, S. et al., 2015. Genetic variants associated with colorectal brain metastases susceptibility and survival. The Pharmacogenomics Journal, 17(1), pp.29–35. Available at: http://dx.doi.org/10.1038/tpj.2015.86.